22056 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Hudis
    Hudis
  4. Kris
    Kris
  5. Saltz
    Saltz
  6. Offit
    Offit
  7. O'Reilly
    O'Reilly
  8. Solit
    Solit
  9. Robson
    Robson
  10. Drilon
    Drilon

Groups

  1. Solid Tumor Oncology Division (22056)
  2. Department of Medicine (22034)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5183)
  6. Gastrointestinal Oncology Service (4640)
  7. Breast Medicine Service (4103)
  8. Surgery (4018)
  9. Department of Pathology and Laboratory Medicine (3422)
  10. Thoracic Oncology (3351)
  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10830)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22056)
  2. Department of Medicine (22034)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5183)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22056)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers
    Meeting Abstract

    Burman, B.; Sherman, E. J.; Kriplani, A.; Michel, L. S.; Dunn, L.; Fetten, J. V.; Warner, E.; Grewal, R. K.; Sabra, M.; Tuttle, R. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • CX-2009, a CD166-directed probody drug conjugate (PDC): Results from the first-in-human study in patients (Pts) with advanced cancer including breast cancer (BC)
    Meeting Abstract

    Boni, V.; Burris, H. A. 3rd; Liu, J. F.; Spira, A. I.; Arkenau, H. T.; Fidler, M. J.; Rosen, L. S.; Sweis, R. F.; Uboha, N. V.; Sanborn, R. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • MSK eConsent: Digitalizing the informed consent process to improve participant engagement and understanding
    Meeting Abstract

    Buckley, M. T.; Lengfellner, J. M.; Koch, M. J.; Search, B.; Hoidra, C.; Lin, M.; Kundu, S.; Cambria, R.; O'Shea, M.; Galle, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The impact of poly ADP ribose polymerase (PARP) inhibitors on clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Moukarzel, L. A.; Ptashkin, R.; Gao, T.; Patel, M.; Caltabellotta, N.; Braunstein, L. Z.; Aghajanian, C.; Hyman, D. M.; Berger, M. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Risk of venous thromboembolism in patients receiving neoadjuvant chemotherapy for ovarian cancer
    Meeting Abstract

    Basaran, D.; Suhner, J.; Sassine, D.; Boerner, T.; Liu, Y. L.; Grisham, R. N.; Tew, W. P.; Gardner, G. J.; Zivanovic, O.; Sonoda, Y.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase I monotherapy dose escalation of RGX-202, a first-in-class oral inhibitor of the SLC6a8/CKB pathway, in patients with advanced gastrointestinal (GI) solid tumors
    Meeting Abstract

    Bendell, J. C.; Strauss, J. F.; Fakih, M.; McRee, A. J.; Hendifar, A. E.; Rosen, L. S.; Cercek, A.; Rowinsky, E. K.; Szarek, M.; Gonsalves, F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Association of neutrophil to lymphocyte ratio (NLR) with efficacy from JAVELIN Renal 101
    Meeting Abstract

    Bilen, M. A.; Rini, B. I.; Motzer, R. J.; Larkin, J. M. G.; Haanen, J. B. A. G.; Albiges, L.; Pagliaro, L. C.; Voog, E.; Lam, E. T.; Kislov, N.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Success and failure of additional immunosuppressants in steroid-refractory pneumonitis related to immune checkpoint blockade
    Meeting Abstract

    Beattie, J.; Fuentes, P.; Rizvi, H.; Luo, J.; Schoenfeld, A. J.; Postow, M. A.; Callahan, M. K.; Warner, A. B.; Chawla, M.; Hellmann, M. D.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Pembrolizumab (pembro) for the treatment of patients with Bacillus Calmette-Guérin (BCG) unresponsive, high-risk (HR) non-muscle-invasive bladder cancer (NMIBC): Over two years follow-up of KEYNOTE-057
    Meeting Abstract

    Balar, A. V.; Kamat, A. M.; Kulkarni, G. S.; Uchio, E. M.; Boormans, J. L.; Bajorin, D. F.; Roumiguié, M.; Singer, E. A.; Krieger, L. E. M.; Grivas, P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prevalence and tissue concordance of BRCA2 copy number loss evaluated by single-cell, shallow whole genome sequencing of circulating tumor cells (CTCs) in castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Barnett, E.; Schonhoft, J.; Schultz, N. D.; Lee, J.; Zaidi, S.; Abida, W.; Carmichael, T.; Dago, A. E.; Solit, D. B.; Wenstrup, R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save